MEDIFOXAMINE ACID METABOLITE
CAS729-89-5
MEDIFOXAMINE ACID METABOLITE (CAS 729-89-5, C14H12O4) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 729-89-5
- Formula
- C14H12O4
- Mol. weight
- 244.24 g/mol
Chemical Specifications
Identifiers
| CAS number | 729-89-5 |
|---|---|
| Product name | MEDIFOXAMINE ACID METABOLITE |
| Synonyms | MEDIFOXAMINE ACID METABOLITE; diphenoxy-aceticaci; diphenoxyaceticacid; 2,2-bis(phenoxy)acetic acid; 2,2-bis(phenoxy)ethanoic acid |
| Molecular formula | C14H12O4 |
| Molecular weight | 244.24 g/mol |
| EC number | 211-981-1 |
Physical and chemical properties
| Boiling Point | 154.8 ( ℃ ) |
|---|
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of MEDIFOXAMINE ACID METABOLITE?
The CAS Registry Number of MEDIFOXAMINE ACID METABOLITE is 729-89-5. MEDIFOXAMINE ACID METABOLITE is also known as MEDIFOXAMINE ACID METABOLITE; diphenoxy-aceticaci; diphenoxyaceticacid.
What is the molecular formula and molecular weight of MEDIFOXAMINE ACID METABOLITE?
The molecular formula of MEDIFOXAMINE ACID METABOLITE is C14H12O4, and its molecular weight is 244.24 g/mol.
How can I request a quotation for MEDIFOXAMINE ACID METABOLITE?
Send an inquiry for MEDIFOXAMINE ACID METABOLITE (CAS 729-89-5) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for MEDIFOXAMINE ACID METABOLITE
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.